Topical and Local TXA in Facelifts - A Randomized Controlled Double Blinded Study

NCT06345833 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

RECRUITING

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Hemophilia
Hemorrhage
Facelift Surgery

Interventions

DRUG: 1%Tranexamic acid with standard local
DRUG: 3% TXA
DRUG: 1% TXA with local plus 3% TXA-soaked pledgets

Sponsor

University of Minnesota